Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT)

Historical Holders from Q2 2021 to Q3 2025

Symbol
NAUT on Nasdaq
CUSIP
63909J108
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
127M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
57.9M
Holdings value
$48.9M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
63
Number of buys
16
Number of sells
-38
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Mallick Parag 17.4% $19.2M 22.3M Parag Mallick Mar 3, 2025
Patel Sujal M 15.7% $17.5M 20.3M Sujal Patel Mar 3, 2025
PERCEPTIVE ADVISORS LLC 10.1% +1% $8.84M $152K 12.8M +1.75% Perceptive Advisors LLC Jun 20, 2025

Institutional Holders of Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 57.9M $48.9M -$1.4M $0.84 63
2025 Q2 59.8M $43.3M -$2.45M $0.72 67
2025 Q1 62.8M $54M -$1.03M $0.86 86
2024 Q4 63.9M $107M -$821K $1.68 86
2024 Q3 64.2M $183M +$1.29M $2.85 81
2024 Q2 64M $150M +$1.61M $2.34 75
2024 Q1 63.2M $186M -$401K $2.94 70
2023 Q4 21.4K $64.1K $2.99 1
2023 Q3 45.1M $142M +$764K $3.16 75
2023 Q2 44.8M $173M +$1.5M $3.87 73
2023 Q1 44.5M $123M -$833K $2.77 73
2022 Q4 46.1M $82.9M -$3.44M $1.80 76
2022 Q3 56.4M $120M -$2.52M $2.12 76
2022 Q2 57.5M $155M +$567K $2.69 79
2022 Q1 56M $244M -$20.6M $4.34 79
2021 Q4 41.9M $217M +$1.58M $5.18 75
2021 Q3 41M $245M +$10.1M $6.14 68
2021 Q2 39M $380M +$379M $10.10 56